Scenic Biotech a leader in the field of modifier therapies for severe genetic disorders has announced a research collaboration with Bristol Myers Squibb aimed at accelerating the development of drug targets owned by Bristol Myers Squibb The collaboration will focus on identifying target biology
Creyon Bio Inc and Cajal Neuroscience have recently announced a collaborative effort to develop innovative treatments for neurodegenerative diseases Creyon specializes
Medison Pharma and Alnylam Pharmaceuticals Inc have announced an expansion of their partnership
Caris Life Sciences a leader in AI TechBio and precision medicine has partnered with COTA Inc an oncology realworld data and analytics firm to enhance their multimodal data offerings
Avenacy a pharmaceutical company specializing in critical injectable medications has introduced Eptifibatide for Injection in the United States This medication approved by the US Food and Drug Administration serves as a generic equivalent for Integrilin for Injection
ReNAgade Therapeutics is broadening its scope in RNA medicine through a collaboration with GanNA Bio This partnership aims to explore the potential of glycobiology in therapeutic applications
Repare Therapeutics Inc a leading clinicalstage precision oncology company and Debiopharm a privatelyowned Swissbased biopharmaceutical company
Astellas Pharma Inc and Poseida Therapeutics Inc today announced that Xyphos Biosciences Inc and Poseida have entered into a research collaboration
G Therapeutics Inc a commercialstage oncology company and Pepper Bio the worlds first transomics drug discovery and development company announced a global licensing agreement
Collegium Pharmaceutical Inc a leading diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical
Boston, MA, USA
Boston, MA, USA
Boston, MA, USA
Boston, MA, USA
Bangkok, Thailand
Pennsylvania, USA
London, UK
Boston, MA, USA
Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Digital Twins have revolutionized the pharmaceutical industry by providing virtual replicas of physical assets and processes This innovative technology offers a comprehensive view of manufacturing
In the realm of healthcare few advancements hold as much promise and controversy as gene editing and genetic engineering These technologies once confined to science fiction are now tangible tools
In the realm of healthcare where every decision has significant financial implications pharmacoeconomics plays a pivotal role It involves the evaluation of the economic impact of pharmaceutical products and services
In the dynamic field of biological sciences the fusion of bioinformatics and computational biology has catalyzed a paradigm shift in genome analysis This synergistic collaboration harnesses cuttingedge computational tools statistical models
Pharmaceutical viral vectors have emerged as powerful tools in gene therapy vaccine development and biotechnology research The ability of viral vectors to deliver genetic material into target cells
Did you know that smart packaging has the potential to revolutionize the pharmaceutical industry With trackandtrace solutions this innovative technology can enhance transparency safety and efficiency in the pharma supply chain
Lowmolecularweight heparins LMWHs are complex anticoagulant drugs made from heparin porcine mucosa starting material Enoxaparin sodium manufactured by Sanofi is one of the most widely prescribed LMWHs
NS Pharmas recent announcement highlights the regulatory acknowledgment by the US Food and Drug Administration underscoring the significance of their investigational candidate NSNCNP This designation is intended for patients who have Duchenne muscular dystrophy amenable to exon skipping therapy
Biotechnology an industry at the forefront of scientific innovation and transformative healthcare solutions
Recent industry pressures brought on by the global COVID pandemic provided critical lessons for the life sciences industry
Today there are more than known rare diseases defined by the European Union as conditions that affect less than in people
Continuous manufacturing methods have been extensively demonstrated to have a significant impact on improving quality
In drug discovery AI is being used to predict the efficacy and safety of potential drug candidates identify new therapeutic targets and optimize clinical trial designs
With more clinical trials getting decentralized and the adoption of AIML witnessing an upward trend